FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.

Local conditions may affect travel, public safety, or daily routines. Stay informed and adjust plans if conditions change.

This report is based on information from NPR Top News, monitored by Alert USA's verified emergency feed.

Residents should be prepared for possible effects on travel, public safety, and daily routines while the situation remains active.

Recommended steps: stay informed via official sources; avoid non-essential travel in the area; secure outdoor items if weather is involved; check on family and neighbors.

Alert USA is tracking this developing situation and will update this report as verified information becomes available.

Verified by Alert USA • NPR TOP NEWS